Insider buying
~$69K7,342 sh @ $9.43
Traded Apr 9, 2025 · filed 2 days later
A Cartesian Therapeutics director paid $69K out of pocket for Cartesian Therapeutics shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 23, 2025
From a 13F filed May 23, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Reduced
Compared with the manager's Q4 2024 13F
572,236
563,272
−1.6%
Share count drives classification; reported value also moves with price
0.42%
Within the filing's reported positions, not the manager's total assets
1
For Q1 2025
Insider buying
Traded Apr 9, 2025 · filed 2 days later
A Cartesian Therapeutics director paid $69K out of pocket for Cartesian Therapeutics shares.
Insider buying
Traded Apr 9, 2025 · filed 2 days later
A Cartesian Therapeutics director paid $308 out of pocket for Cartesian Therapeutics shares.
Insider buying
Traded Apr 9, 2025 · filed 2 days later
A Cartesian Therapeutics director paid $392K out of pocket for Cartesian Therapeutics shares. Shares held went up 8% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.